SurgiQuest, Inc.
8
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
75%
3 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Gastrectomy at Low Pressure Trial - (GALPT)
Role: lead
Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The "CAT5-GS" Study
Role: lead
Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies
Role: collaborator
AirSeal®Insufflation Trocar/CO2 Absorption Study
Role: collaborator
ConMed HelixAR™ ElectroSurgical Generator With Argon Beam Coagulation Technology Study
Role: lead
Pneumoperitoneum Management With SurgiQuest AirSeal at Low vs. Higher Pressure ( PRESSURE )
Role: collaborator
Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System
Role: collaborator
SurgiQuest AirSeal in Robotic Partial Nephrectomy - (TARPAN Study)
Role: lead
All 8 trials loaded